Status:
COMPLETED
Screening for Renal Complications in Children and Young Adults With Major Sickle Cell Disease
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Anemia
Sickle Cell Disease
Eligibility:
All Genders
1-21 years
Phase:
NA
Brief Summary
Sickle cell disease is the subject of targeted neonatal screening (carried out when one of the two parents is from an endemic country - sub-Saharan Africa, South-East Asia, Central America, the Caribb...
Eligibility Criteria
Inclusion
- \- Patient over 1 year old followed up in the Competence Centre at the Nice University Hospital, treated for a major sickle cell disease during the annual check-up
Exclusion
- Pregnant patients (positive urine pregnancy test)
- Patients with other chronic conditions
- Progressive cancer or kidney disease
- Patients who are breastfeeding
Key Trial Info
Start Date :
November 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2024
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT05211037
Start Date
November 15 2022
End Date
October 15 2024
Last Update
November 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France, 06001